CarboMedics mechanical prosthesis: Performance at eight years

Journal of Heart Valve Disease

Volumn 9, Issue 5, 2000, Pages 678-687

  Jamieson, W R E ^a   Fradet, G J ^a   Miyagishima, R T ^a   Henderson, C ^a   Brownlee, R T ^a   Zhang, J ^a   Germann, E ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; CORONARY ARTERY BYPASS GRAFT; DISEASE CLASSIFICATION; EVALUATION; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HUMAN; IMPLANTATION; INTRACARDIAC THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TREATMENT INDICATION;

AGED; AORTIC VALVE; CORONARY ARTERY BYPASS; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMAN; MALE; MIDDLE AGE; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; REOPERATION; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033770008     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mid-term follow-up after heart valve replacement with CarboMedics bileaflet prostheses
2. Four year experience with the CarboMedics valve: The North American experience
3. Seven-and-a-half years clinical experience with the CarboMedics prosthetic heart valve
4. An international experience with the CarboMedics prosthetic heart valve
5. The CarboMedics valve: Experience with 1049 implants
6. Up to eight years' follow-up of 997 patients receiving the CarboMedics prosthetic heart valve
7. Bileaflet mechanical prostheses in mitral and multiple valve replacement surgery. Influence of anticoagulant management on performance
8. Bileaflet mechanical prostheses for aortic valve replacement in patients younger than 65 years and 65 years of age or older: Major thromboembolic and hemorrhagic complications
9. Bileaflet mechanical prostheses performance in mitral position
10. Multiple mechanical valve replacement surgery comparison of St. Jude Medical and CarboMedics prostheses
11. Guidelines for reporting morbidity and mortality after cardiac valvular operations
12. Ann Thorac Surg
13. Proposal for reporting thrombosis, embolism and bleeding after heart valve replacement
14. CarboMedics prosthetic heart valve
15. Long-term results of valve replacement using the CarboMedics prosthesis
16. Mid-term results after heart valve replacement with the CarboMedics bileaflet prosthesis: Experience with 785 implants
17. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses
18. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis
19. The St. Jude Medical prosthesis. A thirteen-year experience
20. The St. Jude Medical valve: Experience with 1000 cases
21. Long-term experience with the St. Jude Medical valve prosthesis
22. Outcome analysis of 245 CarboMedics and St. Jude valves implanted at the same institution
23. Acute thrombotic obstruction with disc prostheses: Diagnostic considerations and fibrinolytic treatment
24. Obstruction of mechanical heart valve prostheses: Clinical aspects and surgical management
25. Mechanical cardiac valve thrombosis. Is thrombectomy justified?
26. Acute thrombosis of prosthetic valves: A multivariate analysis of the risk factors for a life-threatening event
27. Mechanical cardiac valve thrombosis. Is fibrinolysis justified?
28. Thrombolytic treatment for massive thrombosis of prosthetic cardiac valves
29. The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis
30. Thrombolytic therapy of left-sided prosthetic valve thrombosis
31. Thrombolysis for prosthetic valve thrombosis: Indications and results
32. Thrombotic obstruction of bileaflet mechanical prosthetic heart valves: Early diagnosis and management
33. Reoperations for acute prosthetic thrombosis and pannus: An assessment of rates, relationship and risk
34. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves
35. Expanding the use of total mitral valve preservation in combination with implantation of the CarboMedics heart valve prosthesis